Kither Biotech completes Phase 1 KIT2014 clinical study

Novo Nordisk Foundation funds European initiative to accelerate drug discovery for cardiometabolic diseases

Solvonis reports positive bridging data for SVN-002 ahead of planned US Phase 2b

uniQure reports initial six‑month data from first AMT‑260 dose cohort

Incyte Japan wins approval for Minjuvi combination therapy in relapsed or refractory DLBCL

Teijin and Merz secure Japanese approval for additional XEOMIN indications

Alvotech raises USD165m in public offering and private placement

Oncoinvent reports recruitment milestone in Phase 2 study of Radspherin in ovarian cancer

Nortiva Bio launches to develop long-acting oral medicines using LYNX platform

FDA accepts Genentech application for Lunsumio and Polivy combination in large B-cell lymphoma

Ananda Pharma reports Phase 1 pharmacokinetic study results for MRX1

NMD Pharma reports further data from Phase 2a study of ignaseclant

Gesynta Pharma reports progress in Phase 2 trial of vipoglanstat

Bayer completes acquisition of Perfuse Therapeutics to strengthen ophthalmology pipeline

Akeso reports Phase II data for ligufalimab in AML